1. Kruit, Adrian, Grutters, Jan C, Ruven, Henk J T, du Bois, Roland M, van den Bosch, Jules M M. 2006. Chymase gene (CMA1) polymorphisms in Dutch and Japanese sarcoidosis patients. In Respiration; international review of thoracic diseases, 73, 623-33. doi:. https://pubmed.ncbi.nlm.nih.gov/16446531/
2. Shi, Shanping, Ye, Shazhou, Mao, Jianmei, Tang, Xiaoli, Xi, Yang. 2020. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer. In Autoimmunity, 53, 210-217. doi:10.1080/08916934.2020.1735371. https://pubmed.ncbi.nlm.nih.gov/32129682/
3. Zhou, Dongchen, Chen, Yuewei, Wu, Jiaxin, Zheng, Liangrong, Xie, Xudong. 2019. Association between chymase gene polymorphisms and atrial fibrillation in Chinese Han population. In BMC cardiovascular disorders, 19, 321. doi:10.1186/s12872-019-01300-7. https://pubmed.ncbi.nlm.nih.gov/31888494/
4. Charalampidou, Sevastiana, Gintoni, Iphigenia, Avgoustidis, Dimitris, Vassiliou, Stavros, Yapijakis, Christos. . Association Between a High Gene Expression Variant of Chymase and Increased Risk for Basal Cell Carcinoma. In Anticancer research, 42, 5547-5552. doi:10.21873/anticanres.16060. https://pubmed.ncbi.nlm.nih.gov/36288866/
5. Sasaki, Hayato, Imanishi, Madoka, Fujikura, Daisuke, Okamura, Tadashi, Sasaki, Nobuya. 2021. New inducible mast cell-deficient mouse model (Mcpt5/Cma1DTR). In Biochemical and biophysical research communications, 551, 127-132. doi:10.1016/j.bbrc.2021.03.025. https://pubmed.ncbi.nlm.nih.gov/33725574/
智鼠故事 
